These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2574910)

  • 41. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
    Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
    Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Appropriate acid suppression in the treatment of acid-related conditions.
    Howden CW
    Pharmacol Ther; 1994; 63(1):123-34. PubMed ID: 7972343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. History in our lifetime: the changing nature of refractory duodenal ulcer in the era of histamine H2 receptor antagonists.
    Bardhan KD; Nayyar AK; Royston C
    Dig Liver Dis; 2003 Aug; 35(8):529-36. PubMed ID: 14567455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease.
    Lauritsen K; Rutgersson K; Bolling E; Brunner G; Eriksson S; Galmiche JP; Walan A; Archambault AP; Gudjónsson H; Bailey RJ; Bianchi Porro G; Frison L; Havu N; Thompson AB
    Can J Gastroenterol; 1999 Dec; 13(10):806-13. PubMed ID: 10625320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
    Bytzer P; Aalykke C; Rune S; Weywadt L; Gjørup T; Eriksen J; Bonnevie O; Bekker C; Kromann-Andersen H; Kjaergaard J; Rask-Madsen J; Vilien M; Hansen J; Justesen T; Vyberg M; Teglbjaerg PS
    Scand J Gastroenterol; 2000 Oct; 35(10):1023-32. PubMed ID: 11099054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
    Yeomans ND; Tulassay Z; Juhász L; Rácz I; Howard JM; van Rensburg CJ; Swannell AJ; Hawkey CJ
    N Engl J Med; 1998 Mar; 338(11):719-26. PubMed ID: 9494148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.
    Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger S; Zak J
    Am J Med; 1991 Aug; 91(2A):91S-94S. PubMed ID: 1882910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treatment of duodenal ulcer patients.
    Kager L; Lindberg G; Nilsson LH; Seensalu R; Backman L; Granström L; Kollberg B; Sidenvall L; Moberg S; Sörstad J
    Hepatogastroenterology; 1991 Aug; 38(4):287-90. PubMed ID: 1937372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of H2 blockers and omeprazole on peptic secretion: a prospective, randomized study in duodenal ulcer subjects.
    Di Mario F; Dotto P; Vianello F; Germanà B; Grassi SA; Del Favero G; Faggian D; Plebani M; Naccarato R
    Acta Gastroenterol Belg; 1993; 56(2):223-8. PubMed ID: 8103616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM; Faulds D
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omeprazole in the treatment of peptic ulcers resistant to H2-receptor antagonists.
    Guerreiro AS; Neves BC; Quina MG
    Aliment Pharmacol Ther; 1990 Jun; 4(3):309-13. PubMed ID: 1983325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice].
    Yamaura T; Shibata M; Chida Y; Inaba N; Onodera S; Ohnishi H
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):411-20. PubMed ID: 1356898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
    Walan A; Bader JP; Classen M; Lamers CB; Piper DW; Rutgersson K; Eriksson S
    N Engl J Med; 1989 Jan; 320(2):69-75. PubMed ID: 2643037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.
    Deakin M; Williams JG
    Drugs; 1992 Nov; 44(5):709-19. PubMed ID: 1280563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histamine and duodenal ulcer: effect of omeprazole on gastric histamine in patients with duodenal ulcer.
    Man WK; Thompson JN; Baron JH; Spencer J
    Gut; 1986 Apr; 27(4):418-22. PubMed ID: 2420686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors influencing healing of duodenal ulcer. Control of nocturnal secretion by H2 blockade and characteristics of patients who failed to heal.
    Lam SK; Lai CL; Lee LN; Fok KH; Ng MM; Siu KF
    Dig Dis Sci; 1985 Jan; 30(1):45-51. PubMed ID: 2856903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
    Delchier JC; Soule JC; Mignon M; Goldfain D; Cortot A; Travers B; Isal JP; Bader JP
    Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.